Abstracts

494 – Loss of Virologic Control 32 Years After HIV-1 Diagnosis in an Exceptional Elite Controller

Background HIV-1 Exceptional Elite Controllers (EEC) maintain undetectable viremia and halt disease progression more than 20 years after infection in the absence of treatment and may be considered as functionally cured.  However, loss of control in these individuals is unknown. In this study we performed a detailed, longitudinal characterisation of the HIV-1 reservoir, viral evolution…

849 – ALDH Activity as a New Marker of Subclinical Atherosclerosis During ART-Treated HIV-1 Infection

Background Antiretroviral therapy (ART) controls viral replication in people with HIV (PWH), but viral reservoirs (VR) persist and represent a cause for the occurrence of age-related comorbidities, e.g. cardiovascular disease (CVD). We demonstrated that retinoic acid (RA, a vitamin A derivative) increases HIV-1 outgrowth from VR and that microbiota components (e.g., Staphylococcus aureus) promote ALDH…

381 – Extracellular Vesicles’ miRNAs Correlate With Inflammatory Markers in Tanzanians With HIV

Background Although antiretroviral therapy (ART) effectively improves the life expectancy among people living with HIV (PLWH), persistent chronic immune activation and inflammation remain a concern. Recent studies suggest that some miRNA species in extracellular vesicles (EVs) play a role in modulating inflammation. We thus hypothesized that dysregulation of EVs’ miRNAs during HIV infection may be associated…

397 – Analysis of SIV Envelope Diversity During Untreated Infection

Background Viral diversification complicates immune-based cure strategies. SIV-infected Rhesus macaques (RMs) treated with antiretroviral therapy (ART) provide insights into viral dynamics and reservoir persistence in people with HIV-1. We previously described a shift in the composition of infected cell populations during ART, with recently infected cells harboring mutated proviruses decaying more rapidly, and ancestral variants…

394 – Immunometabolic Reprogramming by Caloric Restriction Leads to Protection From SIV in Rhesus Macaques

Background Nutrient metabolism influences HIV-1 replication, immunity, and chronic inflammation but is difficult to target therapeutically. We hypothesized that regulating metabolism via caloric restriction (CR), a safe, anti-aging modality with anti-inflammatory effects could improve SIV disease outcome in rhesus macaques (RMs). Methods Healthy, non-obese, adult male and female RMs (n=6) were experimentally restricted to consume…

369 – Immunometabolism of Innate Lymphocytes in People Living With HIV-1 Versus HIV-2

Background HIV-2 is characterised by more indolent clinical progression than HIV-1, including decreased T-cell activation and limited immune exhaustion. However, it remains unclear how HIV subtypes impact the unconventional lymphocyte compartment, including mucosal-associated invariant T-cells (MAIT), invariant natural killer T-cells (iNKT), and Vδ2+ T-cells which mediate gut barrier defence and mucosal inflammation. To investigate whether the distinct clinical…

352 – Impact of ART Initiation on HIV-1 Soluble gp120 Levels and CD4 Counts in PWH

Background While antiretroviral therapy (ART) suppresses viremia to undetectable levels, people with HIV (PWH) show signs of chronic inflammation and immune dysfunction. Persistent viral antigenic stimulation may contribute to this phenomenon. In a cross-sectional study of ART-treated PWH with undetectable viremia, we recently reported that soluble gp120 (sgp120) was associated with markers of inflammation and…

379 – Genome-Wide Association of NLRP3 Inflammasome Plasma Cytokines in Virally Suppressed People With HIV

Background Despite antiretroviral therapy (ART), people with HIV (PWH) experience higher rates of morbidity and mortality than people without HIV (PWoH), which may be driven by chronic inflammation due to persistent virus. Inflammasome activation leading to proinflammatory cytokine production may be a major driver of this risk. Identification of genes associated with signaling cytokines could…

307 – High Resistance of HIV-1CH040 Envelope Glycoproteins to bNAbs Without Loss of Efficient Viral Entry

Background A transmitter/founder (T/F) HIV-1 strain can establish a productive infection in healthy individuals. HIV-1 envelope glycoproteins (Envs) mediate viral entry and have to maintain a delicate balance between evasion from neutralizing antibodies and entry compatibility. Escape from broadly neutralizing antibodies (bnAbs), which target highly conserved regions in HIV Envs, pose significant challenges to HIV-1…